47 related articles for article (PubMed ID: 38432445)
41. The cell line models to study tyrosine kinase inhibitors in non-small cell lung cancer with mutations in the epidermal growth factor receptor: A scoping review.
Belloni A; Pugnaloni A; Rippo MR; Di Valerio S; Giordani C; Procopio AD; Bronte G
Crit Rev Oncol Hematol; 2024 Feb; 194():104246. PubMed ID: 38135018
[TBL] [Abstract][Full Text] [Related]
42. New strategies in overcoming acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in lung cancer.
Oxnard GR; Arcila ME; Chmielecki J; Ladanyi M; Miller VA; Pao W
Clin Cancer Res; 2011 Sep; 17(17):5530-7. PubMed ID: 21775534
[TBL] [Abstract][Full Text] [Related]
43. PIK3CA mutation as an acquired resistance driver to EGFR-TKIs in non-small cell lung cancer: Clinical challenges and opportunities.
Liu X; Mei W; Zhang P; Zeng C
Pharmacol Res; 2024 Apr; 202():107123. PubMed ID: 38432445
[TBL] [Abstract][Full Text] [Related]
44. Preclinical rationale for PI3K/Akt/mTOR pathway inhibitors as therapy for epidermal growth factor receptor inhibitor-resistant non-small-cell lung cancer.
Gadgeel SM; Wozniak A
Clin Lung Cancer; 2013 Jul; 14(4):322-32. PubMed ID: 23332287
[TBL] [Abstract][Full Text] [Related]
45. Current mechanism of acquired resistance to epidermal growth factor receptor-tyrosine kinase inhibitors and updated therapy strategies in human nonsmall cell lung cancer.
Zhang K; Yuan Q
J Cancer Res Ther; 2016 Dec; 12(Supplement):C131-C137. PubMed ID: 28230005
[TBL] [Abstract][Full Text] [Related]
46. Challenge and countermeasures for EGFR targeted therapy in non-small cell lung cancer.
Tian X; Gu T; Lee MH; Dong Z
Biochim Biophys Acta Rev Cancer; 2022 Jan; 1877(1):188645. PubMed ID: 34793897
[TBL] [Abstract][Full Text] [Related]
47. Advances in molecular-based personalized non-small-cell lung cancer therapy: targeting epidermal growth factor receptor and mechanisms of resistance.
Jotte RM; Spigel DR
Cancer Med; 2015 Nov; 4(11):1621-32. PubMed ID: 26310719
[TBL] [Abstract][Full Text] [Related]
[Previous] [New Search]
